Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of azithromycin eye drops in the treatment of acute bacterial conjunctivitis
CTR20170372Phase 3Completed
- Sponsor
- Guangdong Hongying Technology
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in bacterial conjunctivitis (BC), sponsored by Guangdong Hongying Technology. Started Apr 2017; status: completed.
02
Drugs
azithromycin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on CTR20170372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170372.